PT886679E - Parapoxvírus que contêm adn exógeno, sua produção e sua utilização em vacinas. - Google Patents

Parapoxvírus que contêm adn exógeno, sua produção e sua utilização em vacinas. Download PDF

Info

Publication number: PT886679E
Authority: PT; Portugal
Prior art keywords: gene; ppv; dna; sequence; genomic
Prior art date: 1996-02-28

Application number

PT97904453T

Other languages

English (en)

Portuguese (pt)

Inventor

Norbert Schmeer

Walter Strube

Mathias Buettner

Hans-Joachim Rziha

Original Assignee

Bayer Healthcare Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-02-28

Filing date

1997-02-17

Publication date

2007-08-28

1997-02-17 Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag

2007-08-28 Publication of PT886679E publication Critical patent/PT886679E/pt

Links

241000700639 Parapoxvirus Species 0.000 title description 21
229960005486 vaccine Drugs 0.000 title description 10
238000004519 manufacturing process Methods 0.000 title description 4
238000004803 parallel plate viscometry Methods 0.000 claims description 181
229920000553 poly(phenylenevinylene) Polymers 0.000 claims description 181
238000003780 insertion Methods 0.000 claims description 91
230000037431 insertion Effects 0.000 claims description 91
230000003612 virological effect Effects 0.000 claims description 61
238000012217 deletion Methods 0.000 claims description 36
230000037430 deletion Effects 0.000 claims description 36
241000702619 Porcine parvovirus Species 0.000 claims description 23
244000052769 pathogen Species 0.000 claims description 12
230000001717 pathogenic effect Effects 0.000 claims description 11
238000010188 recombinant method Methods 0.000 claims description 8
239000000427 antigen Substances 0.000 claims description 4
108091007433 antigens Proteins 0.000 claims description 4
102000036639 antigens Human genes 0.000 claims description 4
108090000695 Cytokines Proteins 0.000 claims description 2
102000004127 Cytokines Human genes 0.000 claims description 2
108090000623 proteins and genes Proteins 0.000 description 192
239000012634 fragment Substances 0.000 description 110
108020004414 DNA Proteins 0.000 description 78
238000000034 method Methods 0.000 description 76
239000013612 plasmid Substances 0.000 description 74
108091029865 Exogenous DNA Proteins 0.000 description 70
239000002773 nucleotide Substances 0.000 description 63
108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 62
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 62
125000003729 nucleotide group Chemical group 0.000 description 62
241000700605 Viruses Species 0.000 description 48
150000001875 compounds Chemical class 0.000 description 45
210000004027 cell Anatomy 0.000 description 39
238000002360 preparation method Methods 0.000 description 36
206010057190 Respiratory tract infections Diseases 0.000 description 32
150000001413 amino acids Chemical class 0.000 description 32
238000003752 polymerase chain reaction Methods 0.000 description 32
235000001014 amino acid Nutrition 0.000 description 30
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 29
108700026244 Open Reading Frames Proteins 0.000 description 28
238000010367 cloning Methods 0.000 description 28
108091008146 restriction endonucleases Proteins 0.000 description 28
238000003776 cleavage reaction Methods 0.000 description 25
230000007017 scission Effects 0.000 description 25
241000283898 Ovis Species 0.000 description 24
208000015181 infectious disease Diseases 0.000 description 24
239000013598 vector Substances 0.000 description 24
230000008569 process Effects 0.000 description 23
108091028043 Nucleic acid sequence Proteins 0.000 description 22
239000002585 base Substances 0.000 description 22
238000009396 hybridization Methods 0.000 description 22
150000007523 nucleic acids Chemical class 0.000 description 17
101150093033 pk gene Proteins 0.000 description 17
108020004707 nucleic acids Proteins 0.000 description 16
102000039446 nucleic acids Human genes 0.000 description 16
238000013519 translation Methods 0.000 description 16
108020004999 messenger RNA Proteins 0.000 description 15
239000000047 product Substances 0.000 description 15
108060006633 protein kinase Proteins 0.000 description 15
230000014509 gene expression Effects 0.000 description 14
101100386054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CYS3 gene Proteins 0.000 description 13
235000018102 proteins Nutrition 0.000 description 13
102000004169 proteins and genes Human genes 0.000 description 13
239000000523 sample Substances 0.000 description 13
101150035983 str1 gene Proteins 0.000 description 13
108700039887 Essential Genes Proteins 0.000 description 12
101150025207 VPK2 gene Proteins 0.000 description 12
241000700618 Vaccinia virus Species 0.000 description 12
101100049497 Variola virus (isolate Human/India/Ind3/1967) C14L gene Proteins 0.000 description 12
101710198774 Envelope protein US9 Proteins 0.000 description 11
230000000692 anti-sense effect Effects 0.000 description 11
238000006243 chemical reaction Methods 0.000 description 11
238000002474 experimental method Methods 0.000 description 11
239000000203 mixture Substances 0.000 description 11
241000894007 species Species 0.000 description 11
108091032973 (ribonucleotides)n+m Proteins 0.000 description 10
102000001253 Protein Kinase Human genes 0.000 description 10
238000000746 purification Methods 0.000 description 10
238000001890 transfection Methods 0.000 description 10
241000283690 Bos taurus Species 0.000 description 9
241000700647 Variola virus Species 0.000 description 9
230000006870 function Effects 0.000 description 9
230000002458 infectious effect Effects 0.000 description 9
238000012163 sequencing technique Methods 0.000 description 9
239000000126 substance Substances 0.000 description 9
230000001629 suppression Effects 0.000 description 9
230000002068 genetic effect Effects 0.000 description 8
102220059022 rs786201869 Human genes 0.000 description 8
108091034117 Oligonucleotide Proteins 0.000 description 7
238000002105 Southern blotting Methods 0.000 description 7
230000000694 effects Effects 0.000 description 7
241000588724 Escherichia coli Species 0.000 description 6
108020005202 Viral DNA Proteins 0.000 description 6
238000005119 centrifugation Methods 0.000 description 6
238000010276 construction Methods 0.000 description 6
239000003599 detergent Substances 0.000 description 6
238000011835 investigation Methods 0.000 description 6
239000002609 medium Substances 0.000 description 6
238000012360 testing method Methods 0.000 description 6
241000894006 Bacteria Species 0.000 description 5
108700039964 Duplicate Genes Proteins 0.000 description 5
241000700629 Orthopoxvirus Species 0.000 description 5
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 5
230000003321 amplification Effects 0.000 description 5
238000000338 in vitro Methods 0.000 description 5
239000006166 lysate Substances 0.000 description 5
238000010369 molecular cloning Methods 0.000 description 5
238000003199 nucleic acid amplification method Methods 0.000 description 5
239000013600 plasmid vector Substances 0.000 description 5
230000003252 repetitive effect Effects 0.000 description 5
150000003839 salts Chemical class 0.000 description 5
238000013518 transcription Methods 0.000 description 5
230000035897 transcription Effects 0.000 description 5
101000768957 Acholeplasma phage L2 Uncharacterized 37.2 kDa protein Proteins 0.000 description 4
101000823746 Acidianus ambivalens Uncharacterized 17.7 kDa protein in bps2 3'region Proteins 0.000 description 4
101000916369 Acidianus ambivalens Uncharacterized protein in sor 5'region Proteins 0.000 description 4
101000769342 Acinetobacter guillouiae Uncharacterized protein in rpoN-murA intergenic region Proteins 0.000 description 4
101000823696 Actinobacillus pleuropneumoniae Uncharacterized glycosyltransferase in aroQ 3'region Proteins 0.000 description 4
229920000936 Agarose Polymers 0.000 description 4
101000786513 Agrobacterium tumefaciens (strain 15955) Uncharacterized protein outside the virF region Proteins 0.000 description 4
101000618005 Alkalihalobacillus pseudofirmus (strain ATCC BAA-2126 / JCM 17055 / OF4) Uncharacterized protein BpOF4_00885 Proteins 0.000 description 4
102100020724 Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Human genes 0.000 description 4
101000967489 Azorhizobium caulinodans (strain ATCC 43989 / DSM 5975 / JCM 20966 / LMG 6465 / NBRC 14845 / NCIMB 13405 / ORS 571) Uncharacterized protein AZC_3924 Proteins 0.000 description 4
101000823761 Bacillus licheniformis Uncharacterized 9.4 kDa protein in flaL 3'region Proteins 0.000 description 4
101000819719 Bacillus methanolicus Uncharacterized N-acetyltransferase in lysA 3'region Proteins 0.000 description 4
101000789586 Bacillus subtilis (strain 168) UPF0702 transmembrane protein YkjA Proteins 0.000 description 4
101000792624 Bacillus subtilis (strain 168) Uncharacterized protein YbxH Proteins 0.000 description 4
101000790792 Bacillus subtilis (strain 168) Uncharacterized protein YckC Proteins 0.000 description 4
101000819705 Bacillus subtilis (strain 168) Uncharacterized protein YlxR Proteins 0.000 description 4
101000948218 Bacillus subtilis (strain 168) Uncharacterized protein YtxJ Proteins 0.000 description 4
101000718627 Bacillus thuringiensis subsp. kurstaki Putative RNA polymerase sigma-G factor Proteins 0.000 description 4
101000641200 Bombyx mori densovirus Putative non-structural protein Proteins 0.000 description 4
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
101000947633 Claviceps purpurea Uncharacterized 13.8 kDa protein Proteins 0.000 description 4
101000948901 Enterobacteria phage T4 Uncharacterized 16.0 kDa protein in segB-ipI intergenic region Proteins 0.000 description 4
101000805958 Equine herpesvirus 4 (strain 1942) Virion protein US10 homolog Proteins 0.000 description 4
101000790442 Escherichia coli Insertion element IS2 uncharacterized 11.1 kDa protein Proteins 0.000 description 4
101000788354 Escherichia phage P2 Uncharacterized 8.2 kDa protein in gpA 5'region Proteins 0.000 description 4
101150034234 F9L gene Proteins 0.000 description 4
101000770304 Frankia alni UPF0460 protein in nifX-nifW intergenic region Proteins 0.000 description 4
101000797344 Geobacillus stearothermophilus Putative tRNA (cytidine(34)-2'-O)-methyltransferase Proteins 0.000 description 4
101000748410 Geobacillus stearothermophilus Uncharacterized protein in fumA 3'region Proteins 0.000 description 4
101000772675 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) UPF0438 protein HI_0847 Proteins 0.000 description 4
101000631019 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Uncharacterized protein HI_0350 Proteins 0.000 description 4
101000768938 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 8.9 kDa protein in int-C1 intergenic region Proteins 0.000 description 4
101000785414 Homo sapiens Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Proteins 0.000 description 4
101000782488 Junonia coenia densovirus (isolate pBRJ/1990) Putative non-structural protein NS2 Proteins 0.000 description 4
101000811523 Klebsiella pneumoniae Uncharacterized 55.8 kDa protein in cps region Proteins 0.000 description 4
101000818409 Lactococcus lactis subsp. lactis Uncharacterized HTH-type transcriptional regulator in lacX 3'region Proteins 0.000 description 4
101000878851 Leptolyngbya boryana Putative Fe(2+) transport protein A Proteins 0.000 description 4
241001465754 Metazoa Species 0.000 description 4
101000758828 Methanosarcina barkeri (strain Fusaro / DSM 804) Uncharacterized protein Mbar_A1602 Proteins 0.000 description 4
101001122401 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF3 Proteins 0.000 description 4
101001055788 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) Pentapeptide repeat protein MfpA Proteins 0.000 description 4
241000700635 Orf virus Species 0.000 description 4
101000740670 Orgyia pseudotsugata multicapsid polyhedrosis virus Protein C42 Proteins 0.000 description 4
108091005804 Peptidases Proteins 0.000 description 4
102000035195 Peptidases Human genes 0.000 description 4
101000769182 Photorhabdus luminescens Uncharacterized protein in pnp 3'region Proteins 0.000 description 4
239000004365 Protease Substances 0.000 description 4
101000961392 Pseudescherichia vulneris Uncharacterized 29.9 kDa protein in crtE 3'region Proteins 0.000 description 4
101000731030 Pseudomonas oleovorans Poly(3-hydroxyalkanoate) polymerase 2 Proteins 0.000 description 4
101001065485 Pseudomonas putida Probable fatty acid methyltransferase Proteins 0.000 description 4
101000711023 Rhizobium leguminosarum bv. trifolii Uncharacterized protein in tfuA 3'region Proteins 0.000 description 4
101000948156 Rhodococcus erythropolis Uncharacterized 47.3 kDa protein in thcA 5'region Proteins 0.000 description 4
101000917565 Rhodococcus fascians Uncharacterized 33.6 kDa protein in fasciation locus Proteins 0.000 description 4
101000790284 Saimiriine herpesvirus 2 (strain 488) Uncharacterized 9.5 kDa protein in DHFR 3'region Proteins 0.000 description 4
101000936719 Streptococcus gordonii Accessory Sec system protein Asp3 Proteins 0.000 description 4
101000788499 Streptomyces coelicolor Uncharacterized oxidoreductase in mprA 5'region Proteins 0.000 description 4
101001102841 Streptomyces griseus Purine nucleoside phosphorylase ORF3 Proteins 0.000 description 4
101000708557 Streptomyces lincolnensis Uncharacterized 17.2 kDa protein in melC2-rnhH intergenic region Proteins 0.000 description 4
101000649826 Thermotoga neapolitana Putative anti-sigma factor antagonist TM1081 homolog Proteins 0.000 description 4
101100334096 Vaccinia virus (strain Copenhagen) F9L gene Proteins 0.000 description 4
206010046865 Vaccinia virus infection Diseases 0.000 description 4
101000827562 Vibrio alginolyticus Uncharacterized protein in proC 3'region Proteins 0.000 description 4
101000778915 Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) Uncharacterized membrane protein VP2115 Proteins 0.000 description 4
239000002253 acid Substances 0.000 description 4
238000004458 analytical method Methods 0.000 description 4
238000003556 assay Methods 0.000 description 4
230000001580 bacterial effect Effects 0.000 description 4
239000013602 bacteriophage vector Substances 0.000 description 4
230000033228 biological regulation Effects 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 4
LQQCGEGRINLHDP-UHFFFAOYSA-N carboxyphosphoric acid Chemical compound OC(=O)OP(O)(O)=O LQQCGEGRINLHDP-UHFFFAOYSA-N 0.000 description 4
238000004113 cell culture Methods 0.000 description 4
230000000052 comparative effect Effects 0.000 description 4
230000000295 complement effect Effects 0.000 description 4
238000001514 detection method Methods 0.000 description 4
239000000499 gel Substances 0.000 description 4
101150106093 gpt gene Proteins 0.000 description 4
230000002779 inactivation Effects 0.000 description 4
PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 4
238000002955 isolation Methods 0.000 description 4
230000003362 replicative effect Effects 0.000 description 4
238000011160 research Methods 0.000 description 4
241001515965 unidentified phage Species 0.000 description 4
208000007089 vaccinia Diseases 0.000 description 4
101100408676 Caenorhabditis elegans pmt-1 gene Proteins 0.000 description 3
108091026890 Coding region Proteins 0.000 description 3
108020004705 Codon Proteins 0.000 description 3
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
241000701959 Escherichia virus Lambda Species 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
108700039691 Genetic Promoter Regions Proteins 0.000 description 3
108091029795 Intergenic region Proteins 0.000 description 3
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
241000699666 Mus <mouse, genus> Species 0.000 description 3
238000000636 Northern blotting Methods 0.000 description 3
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
239000007864 aqueous solution Substances 0.000 description 3
239000000872 buffer Substances 0.000 description 3
239000003814 drug Substances 0.000 description 3
238000001962 electrophoresis Methods 0.000 description 3
238000000605 extraction Methods 0.000 description 3
238000001502 gel electrophoresis Methods 0.000 description 3
239000003112 inhibitor Substances 0.000 description 3
HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 3
230000000644 propagated effect Effects 0.000 description 3
239000011541 reaction mixture Substances 0.000 description 3
230000001105 regulatory effect Effects 0.000 description 3
238000012882 sequential analysis Methods 0.000 description 3
230000014621 translational initiation Effects 0.000 description 3
AUXMWYRZQPIXCC-KNIFDHDWSA-N (2s)-2-amino-4-methylpentanoic acid;(2s)-2-aminopropanoic acid Chemical compound C[C@H](N)C(O)=O.CC(C)C[C@H](N)C(O)=O AUXMWYRZQPIXCC-KNIFDHDWSA-N 0.000 description 2
LINMATFDVHBYOS-MBJXGIAVSA-N (2s,3r,4s,5r,6r)-2-[(5-bromo-1h-indol-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C=C12 LINMATFDVHBYOS-MBJXGIAVSA-N 0.000 description 2
OMLWNBVRVJYMBQ-YUMQZZPRSA-N Arg-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O OMLWNBVRVJYMBQ-YUMQZZPRSA-N 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
208000035143 Bacterial infection Diseases 0.000 description 2
241000700199 Cavia porcellus Species 0.000 description 2
241000282693 Cercopithecidae Species 0.000 description 2
108091035707 Consensus sequence Proteins 0.000 description 2
102000053602 DNA Human genes 0.000 description 2
238000001712 DNA sequencing Methods 0.000 description 2
108010053770 Deoxyribonucleases Proteins 0.000 description 2
102000016911 Deoxyribonucleases Human genes 0.000 description 2
108010042407 Endonucleases Proteins 0.000 description 2
102000004533 Endonucleases Human genes 0.000 description 2
108010067770 Endopeptidase K Proteins 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
101710154606 Hemagglutinin Proteins 0.000 description 2
241000282412 Homo Species 0.000 description 2
241000282414 Homo sapiens Species 0.000 description 2
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
CIOWSLJGLSUOME-BQBZGAKWSA-N Lys-Asp Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O CIOWSLJGLSUOME-BQBZGAKWSA-N 0.000 description 2
108020004711 Nucleic Acid Probes Proteins 0.000 description 2
101150073872 ORF3 gene Proteins 0.000 description 2
101710093908 Outer capsid protein VP4 Proteins 0.000 description 2
101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
101710176177 Protein A56 Proteins 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
108091081024 Start codon Proteins 0.000 description 2
241000282898 Sus scrofa Species 0.000 description 2
102000006601 Thymidine Kinase Human genes 0.000 description 2
108020004440 Thymidine kinase Proteins 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
108700005077 Viral Genes Proteins 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
238000000246 agarose gel electrophoresis Methods 0.000 description 2
108010068380 arginylarginine Proteins 0.000 description 2
208000022362 bacterial infectious disease Diseases 0.000 description 2
230000002457 bidirectional effect Effects 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
235000018417 cysteine Nutrition 0.000 description 2
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
230000000120 cytopathologic effect Effects 0.000 description 2
238000006731 degradation reaction Methods 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
230000002255 enzymatic effect Effects 0.000 description 2
210000003527 eukaryotic cell Anatomy 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
238000001914 filtration Methods 0.000 description 2
238000013467 fragmentation Methods 0.000 description 2
238000006062 fragmentation reaction Methods 0.000 description 2
PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol Substances OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
239000000185 hemagglutinin Substances 0.000 description 2
239000002955 immunomodulating agent Substances 0.000 description 2
229940121354 immunomodulator Drugs 0.000 description 2
101150066555 lacZ gene Proteins 0.000 description 2
KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
108010003700 lysyl aspartic acid Proteins 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
IZXGZAJMDLJLMF-UHFFFAOYSA-N methylaminomethanol Chemical compound CNCO IZXGZAJMDLJLMF-UHFFFAOYSA-N 0.000 description 2
208000020298 milker nodule Diseases 0.000 description 2
239000002853 nucleic acid probe Substances 0.000 description 2
239000002245 particle Substances 0.000 description 2
-1 phosphoribosyl Chemical group 0.000 description 2
230000007505 plaque formation Effects 0.000 description 2
SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
239000000843 powder Substances 0.000 description 2
238000012545 processing Methods 0.000 description 2
230000002035 prolonged effect Effects 0.000 description 2
230000009711 regulatory function Effects 0.000 description 2
230000035939 shock Effects 0.000 description 2
235000019333 sodium laurylsulphate Nutrition 0.000 description 2
208000003265 stomatitis Diseases 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
230000007704 transition Effects 0.000 description 2
230000035899 viability Effects 0.000 description 2
238000005160 1H NMR spectroscopy Methods 0.000 description 1
IRGKJPHTQIWQTD-UHFFFAOYSA-N 2,7-dibromopyrene-1,3,6,8-tetrone Chemical compound O=C1C(Br)C(=O)C2=CC=C3C(=O)C(Br)C(=O)C4=CC=C1C2=C43 IRGKJPHTQIWQTD-UHFFFAOYSA-N 0.000 description 1
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
238000012232 AGPC extraction Methods 0.000 description 1
101000787132 Acidithiobacillus ferridurans Uncharacterized 8.2 kDa protein in mobL 3'region Proteins 0.000 description 1
101000827262 Acidithiobacillus ferrooxidans Uncharacterized 18.9 kDa protein in mobE 3'region Proteins 0.000 description 1
241000131104 Actinobacillus sp. Species 0.000 description 1
102100039659 Adenylate cyclase type 3 Human genes 0.000 description 1
101710194150 Adenylate cyclase type 3 Proteins 0.000 description 1
241000256118 Aedes aegypti Species 0.000 description 1
UWQJHXKARZWDIJ-ZLUOBGJFSA-N Ala-Ala-Cys Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(O)=O UWQJHXKARZWDIJ-ZLUOBGJFSA-N 0.000 description 1
IPWKGIFRRBGCJO-IMJSIDKUSA-N Ala-Ser Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](CO)C([O-])=O IPWKGIFRRBGCJO-IMJSIDKUSA-N 0.000 description 1
101000811747 Antithamnion sp. UPF0051 protein in atpA 3'region Proteins 0.000 description 1
101001123982 Arabidopsis thaliana Protochlorophyllide reductase C, chloroplastic Proteins 0.000 description 1
241000180579 Arca Species 0.000 description 1
BMFMQGXDDJALKQ-BYPYZUCNSA-N Argininic acid Chemical class NC(N)=NCCC[C@H](O)C(O)=O BMFMQGXDDJALKQ-BYPYZUCNSA-N 0.000 description 1
KRXIWXCXOARFNT-ZLUOBGJFSA-N Asp-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O KRXIWXCXOARFNT-ZLUOBGJFSA-N 0.000 description 1
UAXIKORUDGGIGA-DCAQKATOSA-N Asp-Pro-Lys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)O)N)C(=O)N[C@@H](CCCCN)C(=O)O UAXIKORUDGGIGA-DCAQKATOSA-N 0.000 description 1
DWBZEJHQQIURML-IMJSIDKUSA-N Asp-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O DWBZEJHQQIURML-IMJSIDKUSA-N 0.000 description 1
241000271566 Aves Species 0.000 description 1
101000827607 Bacillus phage SPP1 Uncharacterized 8.5 kDa protein in GP2-GP6 intergenic region Proteins 0.000 description 1
101000961975 Bacillus thuringiensis Uncharacterized 13.4 kDa protein Proteins 0.000 description 1
102100021257 Beta-secretase 1 Human genes 0.000 description 1
101710150192 Beta-secretase 1 Proteins 0.000 description 1
241000711895 Bovine orthopneumovirus Species 0.000 description 1
241000621124 Bovine papular stomatitis virus Species 0.000 description 1
241000712005 Bovine respirovirus 3 Species 0.000 description 1
102000038625 CMGCs Human genes 0.000 description 1
108091007913 CMGCs Proteins 0.000 description 1
101100408682 Caenorhabditis elegans pmt-2 gene Proteins 0.000 description 1
101000964407 Caldicellulosiruptor saccharolyticus Uncharacterized 10.7 kDa protein in xynB 3'region Proteins 0.000 description 1
241000282832 Camelidae Species 0.000 description 1
241000283707 Capra Species 0.000 description 1
241000282994 Cervidae Species 0.000 description 1
241001495184 Chlamydia sp. Species 0.000 description 1
241000700628 Chordopoxvirinae Species 0.000 description 1
241001062872 Cleyera japonica Species 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
208000008034 Contagious Ecthyma Diseases 0.000 description 1
CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
NOCCABSVTRONIN-CIUDSAMLSA-N Cys-Ala-Leu Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CS)N NOCCABSVTRONIN-CIUDSAMLSA-N 0.000 description 1
TULNGKSILXCZQT-IMJSIDKUSA-N Cys-Asp Chemical compound SC[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O TULNGKSILXCZQT-IMJSIDKUSA-N 0.000 description 1
239000003298 DNA probe Substances 0.000 description 1
201000004624 Dermatitis Diseases 0.000 description 1
206010012735 Diarrhoea Diseases 0.000 description 1
241000243990 Dirofilaria Species 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical group OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
241000244160 Echinococcus Species 0.000 description 1
241000230501 Equine herpesvirus sp. Species 0.000 description 1
108060002716 Exonuclease Proteins 0.000 description 1
241000710831 Flavivirus Species 0.000 description 1
241000710198 Foot-and-mouth disease virus Species 0.000 description 1
OVSKVOOUFAKODB-UWVGGRQHSA-N Gly-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N OVSKVOOUFAKODB-UWVGGRQHSA-N 0.000 description 1
229920002527 Glycogen Polymers 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
101150039660 HA gene Proteins 0.000 description 1
101000768777 Haloferax lucentense (strain DSM 14919 / JCM 9276 / NCIMB 13854 / Aa 2.2) Uncharacterized 50.6 kDa protein in the 5'region of gyrA and gyrB Proteins 0.000 description 1
GIRSNERMXCMDBO-GARJFASQSA-N His-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CC2=CN=CN2)N)C(=O)O GIRSNERMXCMDBO-GARJFASQSA-N 0.000 description 1
101001093181 Homo sapiens Short coiled-coil protein Proteins 0.000 description 1
241001135569 Human adenovirus 5 Species 0.000 description 1
BGZIJZJBXRVBGJ-SXTJYALSSA-N Ile-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N BGZIJZJBXRVBGJ-SXTJYALSSA-N 0.000 description 1
101000607404 Infectious laryngotracheitis virus (strain Thorne V882) Protein UL24 homolog Proteins 0.000 description 1
241000701372 Iridovirus Species 0.000 description 1
101000735632 Klebsiella pneumoniae Uncharacterized 8.8 kDa protein in aacA4 3'region Proteins 0.000 description 1
HSQGMTRYSIHDAC-BQBZGAKWSA-N Leu-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(O)=O HSQGMTRYSIHDAC-BQBZGAKWSA-N 0.000 description 1
LCPYQJIKPJDLLB-UWVGGRQHSA-N Leu-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC(C)C LCPYQJIKPJDLLB-UWVGGRQHSA-N 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
206010031071 Orf Diseases 0.000 description 1
241000283203 Otariidae Species 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
206010033976 Paravaccinia Diseases 0.000 description 1
238000003089 Pariser Parr Pople method Methods 0.000 description 1
241000606580 Pasteurella sp. Species 0.000 description 1
241001494479 Pecora Species 0.000 description 1
108010002747 Pfu DNA polymerase Proteins 0.000 description 1
241001135910 Phage M13mp18 Species 0.000 description 1
MIDZLCFIAINOQN-WPRPVWTQSA-N Phe-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 MIDZLCFIAINOQN-WPRPVWTQSA-N 0.000 description 1
241000283216 Phocidae Species 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
229920000265 Polyparaphenylene Polymers 0.000 description 1
GVUVRRPYYDHHGK-VQVTYTSYSA-N Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 GVUVRRPYYDHHGK-VQVTYTSYSA-N 0.000 description 1
241000282335 Procyon Species 0.000 description 1
101710104624 Proline/betaine transporter Proteins 0.000 description 1
108010059712 Pronase Proteins 0.000 description 1
101710130181 Protochlorophyllide reductase A, chloroplastic Proteins 0.000 description 1
101710138718 Protochlorophyllide reductase B, chloroplastic Proteins 0.000 description 1
241001112090 Pseudovirus Species 0.000 description 1
206010037660 Pyrexia Diseases 0.000 description 1
108091034057 RNA (poly(A)) Proteins 0.000 description 1
108020004518 RNA Probes Proteins 0.000 description 1
238000002123 RNA extraction Methods 0.000 description 1
239000003391 RNA probe Substances 0.000 description 1
241000700564 Rabbit fibroma virus Species 0.000 description 1
241000700159 Rattus Species 0.000 description 1
241001481789 Rupicapra Species 0.000 description 1
241000607149 Salmonella sp. Species 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
102100036292 Short coiled-coil protein Human genes 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
208000036822 Small cell carcinoma of the ovary Diseases 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
101000818100 Spirochaeta aurantia Uncharacterized 12.7 kDa protein in trpE 5'region Proteins 0.000 description 1
101001037658 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) Glucokinase Proteins 0.000 description 1
241000701093 Suid alphaherpesvirus 1 Species 0.000 description 1
102400000368 Surface protein Human genes 0.000 description 1
108010006785 Taq Polymerase Proteins 0.000 description 1
RRRRCRYTLZVCEN-HJGDQZAQSA-N Thr-Leu-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O RRRRCRYTLZVCEN-HJGDQZAQSA-N 0.000 description 1
DSGIVWSDDRDJIO-ZXXMMSQZSA-N Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DSGIVWSDDRDJIO-ZXXMMSQZSA-N 0.000 description 1
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
241000223996 Toxoplasma Species 0.000 description 1
108700009124 Transcription Initiation Site Proteins 0.000 description 1
108090000992 Transferases Proteins 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
241000270506 Tupinambis Species 0.000 description 1
101900209501 Vaccinia virus Thymidine kinase Proteins 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
101100068489 Vicia faba AGPC gene Proteins 0.000 description 1
108010067390 Viral Proteins Proteins 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
101000909800 Xenopus laevis Probable N-acetyltransferase camello Proteins 0.000 description 1
NOXMCJDDSWCSIE-DAGMQNCNSA-N [[(2R,3S,4R,5R)-5-(2-amino-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C1=2NC(N)=NC(=O)C=2C=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O NOXMCJDDSWCSIE-DAGMQNCNSA-N 0.000 description 1
150000001242 acetic acid derivatives Chemical class 0.000 description 1
239000013543 active substance Substances 0.000 description 1
238000001261 affinity purification Methods 0.000 description 1
229910001514 alkali metal chloride Inorganic materials 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
125000000129 anionic group Chemical group 0.000 description 1
SCJNCDSAIRBRIA-DOFZRALJSA-N arachidonyl-2'-chloroethylamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCCl SCJNCDSAIRBRIA-DOFZRALJSA-N 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
244000309466 calf Species 0.000 description 1
150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
IWQKNYVWZZYCQD-UHFFFAOYSA-N carboxyoxy(phenyl)phosphinic acid Chemical compound C(=O)(O)OP(O)(=O)C1=CC=CC=C1 IWQKNYVWZZYCQD-UHFFFAOYSA-N 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
239000013592 cell lysate Substances 0.000 description 1
239000013553 cell monolayer Substances 0.000 description 1
230000008859 change Effects 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
229910052681 coesite Inorganic materials 0.000 description 1
238000004590 computer program Methods 0.000 description 1
239000000470 constituent Substances 0.000 description 1
201000005332 contagious pustular dermatitis Diseases 0.000 description 1
239000013601 cosmid vector Substances 0.000 description 1
229910052906 cristobalite Inorganic materials 0.000 description 1
229960004397 cyclophosphamide Drugs 0.000 description 1
230000007423 decrease Effects 0.000 description 1
238000000432 density-gradient centrifugation Methods 0.000 description 1
230000029087 digestion Effects 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
238000011037 discontinuous sequential dilution Methods 0.000 description 1
230000001819 effect on gene Effects 0.000 description 1
238000004520 electroporation Methods 0.000 description 1
230000007515 enzymatic degradation Effects 0.000 description 1
230000006862 enzymatic digestion Effects 0.000 description 1
238000001976 enzyme digestion Methods 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
102000013165 exonuclease Human genes 0.000 description 1
108010092809 exonuclease Bal 31 Proteins 0.000 description 1
238000005194 fractionation Methods 0.000 description 1
108020001507 fusion proteins Proteins 0.000 description 1
102000037865 fusion proteins Human genes 0.000 description 1
230000004545 gene duplication Effects 0.000 description 1
229940096919 glycogen Drugs 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
238000003306 harvesting Methods 0.000 description 1
230000002519 immonomodulatory effect Effects 0.000 description 1
230000008105 immune reaction Effects 0.000 description 1
230000036039 immunity Effects 0.000 description 1
238000010185 immunofluorescence analysis Methods 0.000 description 1
238000001114 immunoprecipitation Methods 0.000 description 1
230000003308 immunostimulating effect Effects 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
101150081094 ispG gene Proteins 0.000 description 1
210000003292 kidney cell Anatomy 0.000 description 1
238000002372 labelling Methods 0.000 description 1
230000003902 lesion Effects 0.000 description 1
108010071185 leucyl-alanine Proteins 0.000 description 1
108010091798 leucylleucine Proteins 0.000 description 1
239000002502 liposome Substances 0.000 description 1
230000004807 localization Effects 0.000 description 1
230000005923 long-lasting effect Effects 0.000 description 1
108010064235 lysylglycine Proteins 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
230000000877 morphologic effect Effects 0.000 description 1
238000002703 mutagenesis Methods 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
230000035772 mutation Effects 0.000 description 1
HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
229960000951 mycophenolic acid Drugs 0.000 description 1
LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
VMPITZXILSNTON-UHFFFAOYSA-N o-anisidine Chemical compound COC1=CC=CC=C1N VMPITZXILSNTON-UHFFFAOYSA-N 0.000 description 1
230000008520 organization Effects 0.000 description 1
108700010766 orthopoxvirus proteins Proteins 0.000 description 1
201000005292 ovarian small cell carcinoma Diseases 0.000 description 1
238000007500 overflow downdraw method Methods 0.000 description 1
244000045947 parasite Species 0.000 description 1
230000007918 pathogenicity Effects 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
108010024607 phenylalanylalanine Proteins 0.000 description 1
235000021317 phosphate Nutrition 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
235000011056 potassium acetate Nutrition 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
108010070643 prolylglutamic acid Proteins 0.000 description 1
230000000069 prophylactic effect Effects 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000017854 proteolysis Effects 0.000 description 1
230000004144 purine metabolism Effects 0.000 description 1
238000000163 radioactive labelling Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000010076 replication Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
239000006152 selective media Substances 0.000 description 1
230000000405 serological effect Effects 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
235000012239 silicon dioxide Nutrition 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
235000002639 sodium chloride Nutrition 0.000 description 1
239000000243 solution Substances 0.000 description 1
239000002904 solvent Substances 0.000 description 1
238000000527 sonication Methods 0.000 description 1
239000007858 starting material Substances 0.000 description 1
229910052682 stishovite Inorganic materials 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
238000004448 titration Methods 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000009466 transformation Effects 0.000 description 1
230000010474 transient expression Effects 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
229910052905 tridymite Inorganic materials 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
241000712461 unidentified influenza virus Species 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
238000012725 vapour phase polymerization Methods 0.000 description 1
229940126580 vector vaccine Drugs 0.000 description 1
238000012795 verification Methods 0.000 description 1
230000029812 viral genome replication Effects 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
210000002845 virion Anatomy 0.000 description 1
230000001018 virulence Effects 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
244000000023 zoonotic pathogen Species 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/065—Poxviridae, e.g. avipoxvirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24241—Use of virus, viral particle or viral elements as a vector
- C12N2710/24243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Plant Pathology (AREA)
Epidemiology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Mycology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

PT97904453T 1996-02-28 1997-02-17 Parapoxvírus que contêm adn exógeno, sua produção e sua utilização em vacinas. PT886679E (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19607458		1996-02-28
DE19639601A DE19639601A1 (de)	1996-02-28	1996-09-26	Parapockenviren, die Fremd-DNA enthalten, ihre Herstellung und ihre Verwendung in Impfstoffen

Publications (1)

Publication Number	Publication Date
PT886679E true PT886679E (pt)	2007-08-28

Family

ID=7786638

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT97904453T PT886679E (pt)	1996-02-28	1997-02-17	Parapoxvírus que contêm adn exógeno, sua produção e sua utilização em vacinas.

Country Status (4)

Country	Link
KR (1)	KR19990087208A (de)
DE (1)	DE19639601A1 (de)
PT (1)	PT886679E (de)
YU (1)	YU36698A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7597886B2 (en)	1994-11-07	2009-10-06	Human Genome Sciences, Inc.	Tumor necrosis factor-gamma
US7820798B2 (en)	1994-11-07	2010-10-26	Human Genome Sciences, Inc.	Tumor necrosis factor-gamma
DE19813774A1 (de) *	1998-03-27	1999-09-30	Max Planck Gesellschaft	Parapockenvirus-kodierter vaskulärer Endothelzell Wachstumsfaktor (PPV-VEGF)
WO2000050620A2 (en)	1999-02-26	2000-08-31	Human Genome Sciences, Inc.	Human endokine alpha and methods of use
WO2001077137A1 (en)	2000-04-12	2001-10-18	Human Genome Sciences, Inc.	Albumin fusion proteins
DE19922407A1 (de) *	1999-05-14	2000-11-16	Bayer Ag	Organ-, gewebs- und zellspezifisches Immuntherapeutikum für chronische virale Infektionen, sowie entzündliche, degenerative und proliferative Erkrankungen insbesondere der Leber sowie Krebs auf der Basis von rekombinantem Parapoxvirus
EP2277889B1 (de)	2001-12-21	2014-07-09	Human Genome Sciences, Inc.	Fusionsproteine von Albumin und Interferon beta
EP1531848A4 (de)	2002-06-10	2007-03-28	Vaccinex Inc	Differential exprimiertes gen bei brust- und blasenkrebs und kodierte polypeptide
JP5690593B2 (ja)	2007-12-26	2015-03-25	ヴァクシネックス，インコーポレイテッド	抗ｃ３５抗体併用療法および方法
DE102015111756A1 (de) *	2015-07-20	2017-01-26	Eberhard Karls Universität Tübingen Medizinische Fakultät	Rekombinanter Orf-Virus-Vektor

1996
- 1996-09-26 DE DE19639601A patent/DE19639601A1/de not_active Withdrawn
1997
- 1997-02-17 KR KR1019980706605A patent/KR19990087208A/ko not_active Ceased
- 1997-02-17 PT PT97904453T patent/PT886679E/pt unknown
1998
- 1998-08-27 YU YU36698A patent/YU36698A/sh unknown

Also Published As

Publication number	Publication date
KR19990087208A (ko)	1999-12-15
DE19639601A1 (de)	1997-09-04
YU36698A (sh)	2001-05-28

Publication	Publication Date	Title
JP3044062B2 (ja)	2000-05-22	組換えポックスウイルス宿主選択系
Somogyi et al.	1993	Fowlpox virus host range restriction: gene expression, DNA replication, and morphogenesis in nonpermissive mammalian cells
CN100494388C (zh)	2009-06-03	改进的安卡拉痘苗病毒(mva)基因组中作为插入位点的基因间隔区
EP3475433B1 (de)	2021-07-21	Adenoviraler vektor
US5225336A (en)	1993-07-06	Recombinant poxvirus host range selection system
US5670367A (en)	1997-09-23	Recombinant fowlpox virus
US5420026A (en)	1995-05-30	Self-assembling replication defective hybrid virus particles
Volkmer et al.	1987	Cytolytic T lymphocyte recognition of the murine cytomegalovirus nonstructural immediate-early protein pp89 expressed by recombinant vaccinia virus.
EP3456349A1 (de)	2019-03-20	Optimierter früher/später promoter kombiniert mit wiederholter impfung zur begünstigung der zytotoxischen t-zellenreaktion gegen rekombinantes antigen in mva-impfstoffen
AU2011224111A1 (en)	2011-10-13	Recombinant porcine adenovirus vector
ES2287949T3 (es)	2007-12-16	Parapoxvirus, que contienen adn foraneo, su obtencion y su empleo en vacunas.
EP0652287B1 (de)	2003-03-05	Poxvirusvektoren und deren Anwendung als Impstoff gegen Katzenansteckende Peritonitis-Viruskrankheit
PT886679E (pt)	2007-08-28	Parapoxvírus que contêm adn exógeno, sua produção e sua utilização em vacinas.
JP2007254489A (ja)	2007-10-04	Ｈｔｌｖ抗原を発現する組換え弱毒化ポックスウイルスを含有する免疫原性組成物
CA2372709C (en)	2011-10-25	Vector for integration of heterologous sequences into poxviral genomes
Marsland et al.	2003	Construction of a recombinant orf virus that expresses an Echinococcus granulosus vaccine antigen from a novel genomic insertion site
US5759552A (en)	1998-06-02	Marek's disease virus recombinant poxvirus vaccine
JPH07503843A (ja)	1995-04-27	マレック病ウイルス組換えポックスウイルスワクチン
Scheiflinger et al.	1997	Role of the fowlpox virus thymidine kinase genefor the growth of FPV recombinants in cell culture
EP0365349A1 (de)	1990-04-25	Geflügelpockenvirus-Promoter
Hall et al.	1996	TheAmsacta mooreiEntomopoxvirus Spheroidin Gene Is Improperly Transcribed in Vertebrate Poxviruses
Furth et al.	1997	Construction of a viable BHV1 mutant lacking mostof the short unique region
AU757683B2 (en)	2003-02-27	Recombinant porcine adenovirus vector
Mahony et al.	2003	Rapid and efficient construction of recombinant bovine herpesvirus 1 genomes
IE902696A1 (en)	1991-02-27	Avipox virus promoters